REGULATE-PCI trial--Author's reply.
Publication
, Journal Article
Lincoff, AM; Alexander, JH; Mehran, R
Published in: Lancet
April 9, 2016
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
April 9, 2016
Volume
387
Issue
10027
Start / End Page
1510 / 1511
Location
England
Related Subject Headings
- Percutaneous Coronary Intervention
- Peptide Fragments
- Male
- Humans
- General & Internal Medicine
- Female
- Factor IXa
- Aptamers, Nucleotide
- Anticoagulants
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lincoff, A. M., Alexander, J. H., & Mehran, R. (2016). REGULATE-PCI trial--Author's reply. Lancet, 387(10027), 1510–1511. https://doi.org/10.1016/S0140-6736(16)00694-2
Lincoff, A Michael, John H. Alexander, and Roxana Mehran. “REGULATE-PCI trial--Author's reply.” Lancet 387, no. 10027 (April 9, 2016): 1510–11. https://doi.org/10.1016/S0140-6736(16)00694-2.
Lincoff AM, Alexander JH, Mehran R. REGULATE-PCI trial--Author's reply. Lancet. 2016 Apr 9;387(10027):1510–1.
Lincoff, A. Michael, et al. “REGULATE-PCI trial--Author's reply.” Lancet, vol. 387, no. 10027, Apr. 2016, pp. 1510–11. Pubmed, doi:10.1016/S0140-6736(16)00694-2.
Lincoff AM, Alexander JH, Mehran R. REGULATE-PCI trial--Author's reply. Lancet. 2016 Apr 9;387(10027):1510–1511.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
April 9, 2016
Volume
387
Issue
10027
Start / End Page
1510 / 1511
Location
England
Related Subject Headings
- Percutaneous Coronary Intervention
- Peptide Fragments
- Male
- Humans
- General & Internal Medicine
- Female
- Factor IXa
- Aptamers, Nucleotide
- Anticoagulants
- 42 Health sciences